Inj. GS (Miracure) 20mg / ml | VetSafeCare.Com

Inj.

GS (Miracure)

GS-441524 — Others / Imported
20mg / ml · 10 ml

Alternatives

1

Routes

SC

Presentations

3

Brand overview Generic profile Browse alternatives

Presentation

Inj. GS (Miracure)

SC Injection · Subcutaneous · 20mg / ml · 10 ml

Dose rules

No structured dose rules are linked to this brand yet.

Dose reference

Cat

  • Wet FIP Base Dosage: Typically requires 6 mg/kg.

  • Ocular FIP Base Dosage: Typically requires 8 mg/kg.

  • Neurological FIP Base Dosage: Typically requires 10 mg/kg.

Clinical notes

Applications:

N/A

Indication Notes:

It is a specialized veterinary antiviral medication primarily manufactured to treat Feline Infectious Peritonitis (FIP) in cats. [1]

Avoid In:

N/A

Contraindication Notes:

The pharmacology of GS-441524 focuses on blocking viral replication. Because FIP is a complex disease, understanding how this drug behaves in a cat's body and how it co-exists with other medications is critical to treatment success.

Pharmacology & Mechanism of Action

  • Drug Class: It is a small-molecule nucleoside analog (specifically an adenosine nucleotide analog).

  • Cellular Activation: Once injected or swallowed, the cat's cells absorb the molecule and add three phosphate groups to it, converting it into an active triphosphate structure.

  • Chain Termination: When the feline coronavirus attempts to duplicate its genetic code using its native RNA-dependent RNA polymerase, it mistakenly grabs the activated GS-441524 instead of natural ATP. Once incorporated, it triggers delayed chain termination, completely freezing the virus's ability to replicate.

  • Pharmacokinetics: The drug has an elimination half-life of roughly 5 hours. It clears smoothly from the blood within 24 hours, meaning it requires strict once-daily (every 24 hours) dosing to maintain a protective viral-blocking threshold. It is primarily excreted through the urine.

Drug Interactions

GS-441524 is generally considered highly compatible with standard supportive veterinary therapies. However, a few specific drug groups require adjustments or caution:

1. Counter-Indicated or Cautionary Combinations

  • Fluoroquinolones & General Antibiotics: Antibiotics are often prescribed to treat secondary infections or injection-site sores. However, giving oral antibiotics at the exact same time as oral GS-441524 can cause them to compete for absorption pathways in the GI tract. Caregivers must stagger oral doses by at least 2 to 3 hours.

  • Immunosuppressants & Corticosteroids (e.g., Prednisolone): While small, short-term doses of steroids are sometimes used in the first few days of treatment to fight severe inflammation, long-term use should be avoided. Steroids blunt the cat's natural immune response, which needs to work alongside the antiviral to completely clear the mutated coronavirus.

  • Chloroquine / Hydroxychloroquine: Based on human data regarding its parent drug (Remdesivir), these compounds can actively decrease the therapeutic antiviral potency of the GS molecule and should be entirely avoided.

2. Synergistic (Positive) Interactions

  • Itraconazole: Clinical research indicates that this specific antifungal medication displays a strong synergistic effect when paired with GS-441524, enhancing the drug's overall capacity to suppress the virus.

  • Safe Supportive Medications: There are no known negative interactions between GS-441524 and common supportive care medications like Maropitant (anti-nausea), Gabapentin (pain/sedation), Mirtazapine (appetite stimulant), or Vitamin B12 supplements.